Emmaus Life Sciences, Inc.
EMMA
$0.0115
-$0.0024-17.27%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 886.00K | 1.33M | 1.39M | 1.26M | 1.53M |
| Total Receivables | 2.07M | 2.06M | 2.62M | 4.99M | 4.60M |
| Inventory | 1.31M | 1.44M | 1.64M | 1.61M | 1.63M |
| Prepaid Expenses | 525.00K | 611.00K | 894.00K | 530.00K | 607.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 220.00K | 211.00K | 226.00K | 817.00K | 654.00K |
| Total Current Assets | 5.02M | 5.65M | 6.77M | 9.20M | 9.01M |
|
|
|||||
| Total Current Assets | 5.02M | 5.65M | 6.77M | 9.20M | 9.01M |
| Net Property, Plant & Equipment | 973.00K | 1.37M | 1.58M | 1.77M | 1.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 168.00K | 222.00K | 222.00K | 312.00K | 308.00K |
| Total Assets | 23.34M | 22.48M | 23.60M | 27.34M | 25.94M |
|
|
|||||
| Total Accounts Payable | 750.00K | 520.00K | 594.00K | 578.00K | 1.69M |
| Total Accrued Expenses | 21.62M | 22.89M | 21.32M | 22.63M | 20.23M |
| Short-term Debt | 11.40M | 10.64M | 10.47M | 10.69M | 10.65M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.15M | 19.54M | 19.44M | 18.53M | 17.23M |
| Total Finance Division Other Current Liabilities | 11.15M | 11.32M | 11.74M | 11.70M | 14.22M |
| Total Other Current Liabilities | 11.15M | 11.32M | 11.74M | 11.70M | 14.22M |
| Total Current Liabilities | 62.08M | 64.92M | 63.56M | 64.13M | 64.03M |
|
|
|||||
| Total Current Liabilities | 62.08M | 64.92M | 63.56M | 64.13M | 64.03M |
| Long-Term Debt | 2.26M | 2.25M | 2.25M | 2.24M | 2.24M |
| Short-term Debt | 11.40M | 10.64M | 10.47M | 10.69M | 10.65M |
| Capital Leases | 1.58M | 544.00K | 815.00K | 1.08M | 1.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.13M | 13.37M | 13.47M | 13.68M | 15.37M |
| Total Liabilities | 79.05M | 81.08M | 80.08M | 81.12M | 82.95M |
|
|
|||||
| Common Stock & APIC | 225.97M | 225.97M | 225.96M | 225.93M | 225.90M |
| Retained Earnings | -266.04M | -264.91M | -262.58M | -260.83M | -262.65M |
| Treasury Stock & Other | -15.63M | -19.67M | -19.86M | -18.89M | -20.26M |
| Total Common Equity | -55.70M | -58.60M | -56.48M | -53.78M | -57.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.70M | -58.60M | -56.48M | -53.78M | -57.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.70M | -58.60M | -56.48M | -53.78M | -57.01M |
|
|
|||||